TLPH
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-06-22–present
Board Member
Talphera, Inc. (TLPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Talphera, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLPH alertsJoseph Todisco is recorded as Board Member at Talphera, Inc. (TLPH) since June 22, 2026. Talphera, Inc. reported in an 8-K filed June 23, 2026 that Joseph Todisco was appointed Class III director, effective June 22, 2026. Talphera, Inc. reported in an 8-K filed October 16, 2025 that Joseph Todisco was appointed Class III member of the board of directors and member of the compensation committee, effective October 14, 2025. Talphera, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Talphera, Inc. includes Vincent J. Angotti (CEO and Board Member), Raffi Asadorian (CFO), Abhinav Jain (Board Member) and 7 others.
“Marina Bozilenko, Joseph Todisco and Mark Wan were elected as Class III directors, by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2029 Annual Meeting of Stockholders by the following vote:”
“On October 14, 2025, the board of directors of Talphera, Inc. appointed Joseph Todisco as a Class III member of the board of directors and member of the compensation committee to hold office for the balance of a term expiring at our 2026 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
2026-06-22–present
TLPH
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-06-22–present